Cellectis' off-the-shelf CAR T-Cells treat 11-month old with leukaemia
An ‘off-the-shelf’ CAR (chimeric-antigen receptor) T-Cell therapy from Cellectis has shown to have successfully treated a baby girl with leukaemia.
Archives for November 10, 2015
Clarification
Repligen halting one Protein A media programme but still in resin market
Repligen has halted a Protein A media programme due to mixed feedback and dilution risks but says it is still a player in the $350m market.
Unilife undecided on takeover plans; gives December 31 deadline
Unilife CEO Alan Shortall yesterday confirmed the drug delivery company is still “receiving interest from several parties under the strategic review process” and set a deadline of December 31 to announce any potential takeover. The company received its...
Big Biopharma? ABEC launches 4,300L single-use bioreactor
ABEC has launched the world’s largest single-use bioreactor with a working volume of 3,500L.